IDEXX LABORATORIES INC (IDXX) Stock Fundamental Analysis
USA - NASDAQ:IDXX - US45168D1046 - Common Stock
647.96 USD
+3.97 (+0.62%)
Taking everything into account, IDXX scores 7 out of 10 in our fundamental rating. IDXX was compared to 191 industry peers in the Health Care Equipment & Supplies industry. IDXX has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. IDXX has a decent growth rate and is not valued too expensively. With these ratings, IDXX could be worth investigating further for quality investing!.
1. Profitability
1.1 Basic Checks
In the past year IDXX was profitable.
In the past year IDXX had a positive cash flow from operations.
In the past 5 years IDXX has always been profitable.
IDXX had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
IDXX has a Return On Assets of 29.59%. This is amongst the best in the industry. IDXX outperforms 98.95% of its industry peers.
IDXX's Return On Equity of 67.56% is amongst the best of the industry. IDXX outperforms 99.48% of its industry peers.
IDXX has a Return On Invested Capital of 37.30%. This is amongst the best in the industry. IDXX outperforms 100.00% of its industry peers.
IDXX had an Average Return On Invested Capital over the past 3 years of 35.08%. This is significantly above the industry average of 8.46%.
The last Return On Invested Capital (37.30%) for IDXX is above the 3 year average (35.08%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 29.59% | ||
| ROE | 67.56% | ||
| ROIC | 37.3% |
ROA(3y)25.87%
ROA(5y)26.7%
ROE(3y)74.71%
ROE(5y)84.83%
ROIC(3y)35.08%
ROIC(5y)36.07%
1.3 Margins
The Profit Margin of IDXX (24.41%) is better than 94.24% of its industry peers.
In the last couple of years the Profit Margin of IDXX has grown nicely.
With an excellent Operating Margin value of 31.09%, IDXX belongs to the best of the industry, outperforming 97.91% of the companies in the same industry.
In the last couple of years the Operating Margin of IDXX has grown nicely.
The Gross Margin of IDXX (61.54%) is better than 62.30% of its industry peers.
In the last couple of years the Gross Margin of IDXX has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 31.09% | ||
| PM (TTM) | 24.41% | ||
| GM | 61.54% |
OM growth 3Y0.02%
OM growth 5Y4.78%
PM growth 3Y-0.55%
PM growth 5Y5.09%
GM growth 3Y1.27%
GM growth 5Y1.47%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so IDXX is creating value.
The number of shares outstanding for IDXX has been reduced compared to 1 year ago.
Compared to 5 years ago, IDXX has less shares outstanding
The debt/assets ratio for IDXX has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 21.49 indicates that IDXX is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 21.49, IDXX belongs to the top of the industry, outperforming 95.81% of the companies in the same industry.
The Debt to FCF ratio of IDXX is 1.43, which is an excellent value as it means it would take IDXX, only 1.43 years of fcf income to pay off all of its debts.
IDXX's Debt to FCF ratio of 1.43 is amongst the best of the industry. IDXX outperforms 90.05% of its industry peers.
IDXX has a Debt/Equity ratio of 0.71. This is a neutral value indicating IDXX is somewhat dependend on debt financing.
IDXX has a worse Debt to Equity ratio (0.71) than 71.73% of its industry peers.
Even though the debt/equity ratio score it not favorable for IDXX, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.71 | ||
| Debt/FCF | 1.43 | ||
| Altman-Z | 21.49 |
ROIC/WACC4.12
WACC9.06%
2.3 Liquidity
IDXX has a Current Ratio of 1.11. This is a normal value and indicates that IDXX is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of IDXX (1.11) is worse than 85.86% of its industry peers.
A Quick Ratio of 0.79 indicates that IDXX may have some problems paying its short term obligations.
IDXX's Quick ratio of 0.79 is on the low side compared to the rest of the industry. IDXX is outperformed by 86.39% of its industry peers.
IDXX does not score too well on the current and quick ratio evaluation. However, as it has excellent solvency and profitability, these ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.11 | ||
| Quick Ratio | 0.79 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 12.45% over the past year.
The Earnings Per Share has been growing by 18.18% on average over the past years. This is quite good.
IDXX shows a small growth in Revenue. In the last year, the Revenue has grown by 6.68%.
The Revenue has been growing by 10.12% on average over the past years. This is quite good.
EPS 1Y (TTM)12.45%
EPS 3Y9.32%
EPS 5Y18.18%
EPS Q2Q%20.2%
Revenue 1Y (TTM)6.68%
Revenue growth 3Y6.62%
Revenue growth 5Y10.12%
Sales Q2Q%10.55%
3.2 Future
IDXX is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.68% yearly.
The Revenue is expected to grow by 8.69% on average over the next years. This is quite good.
EPS Next Y14.26%
EPS Next 2Y13.24%
EPS Next 3Y13.08%
EPS Next 5Y11.68%
Revenue Next Year9.02%
Revenue Next 2Y8.62%
Revenue Next 3Y8.63%
Revenue Next 5Y8.69%
3.3 Evolution
The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 53.95, which means the current valuation is very expensive for IDXX.
Compared to the rest of the industry, the Price/Earnings ratio of IDXX indicates a somewhat cheap valuation: IDXX is cheaper than 68.06% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.27, IDXX is valued quite expensively.
A Price/Forward Earnings ratio of 44.91 indicates a quite expensive valuation of IDXX.
69.63% of the companies in the same industry are more expensive than IDXX, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 22.77. IDXX is valued rather expensively when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 53.95 | ||
| Fwd PE | 44.91 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, IDXX is valued a bit cheaper than the industry average as 69.63% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, IDXX is valued a bit cheaper than the industry average as 73.30% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 66.94 | ||
| EV/EBITDA | 37.25 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates IDXX does not grow enough to justify the current Price/Earnings ratio.
The excellent profitability rating of IDXX may justify a higher PE ratio.
IDXX's earnings are expected to grow with 13.08% in the coming years. This may justify a more expensive valuation.
PEG (NY)3.78
PEG (5Y)2.97
EPS Next 2Y13.24%
EPS Next 3Y13.08%
5. Dividend
5.1 Amount
No dividends for IDXX!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:IDXX (9/16/2025, 2:53:55 PM)
647.96
+3.97 (+0.62%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners97.51%
Inst Owner Change-1.47%
Ins Owners0.19%
Ins Owner Change2.22%
Market Cap51.84B
Analysts79.05
Price Target691.47 (6.71%)
Short Float %2.58%
Short Ratio3.56
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)4.76%
Min EPS beat(2)1.72%
Max EPS beat(2)7.81%
EPS beat(4)4
Avg EPS beat(4)4.73%
Min EPS beat(4)1.72%
Max EPS beat(4)7.81%
EPS beat(8)8
Avg EPS beat(8)4.6%
EPS beat(12)12
Avg EPS beat(12)4.41%
EPS beat(16)14
Avg EPS beat(16)3.9%
Revenue beat(2)1
Avg Revenue beat(2)-0.02%
Min Revenue beat(2)-1.92%
Max Revenue beat(2)1.88%
Revenue beat(4)2
Avg Revenue beat(4)-0.58%
Min Revenue beat(4)-2.33%
Max Revenue beat(4)1.88%
Revenue beat(8)2
Avg Revenue beat(8)-1.32%
Revenue beat(12)2
Avg Revenue beat(12)-1.2%
Revenue beat(16)3
Avg Revenue beat(16)-1.19%
PT rev (1m)14.42%
PT rev (3m)31.49%
EPS NQ rev (1m)0%
EPS NQ rev (3m)1.41%
EPS NY rev (1m)3.54%
EPS NY rev (3m)3.82%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.73%
Revenue NY rev (1m)1.94%
Revenue NY rev (3m)2.32%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 53.95 | ||
| Fwd PE | 44.91 | ||
| P/S | 12.84 | ||
| P/FCF | 66.94 | ||
| P/OCF | 57.23 | ||
| P/B | 35.53 | ||
| P/tB | 55.11 | ||
| EV/EBITDA | 37.25 |
EPS(TTM)12.01
EY1.85%
EPS(NY)14.43
Fwd EY2.23%
FCF(TTM)9.68
FCFY1.49%
OCF(TTM)11.32
OCFY1.75%
SpS50.47
BVpS18.24
TBVpS11.76
PEG (NY)3.78
PEG (5Y)2.97
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 29.59% | ||
| ROE | 67.56% | ||
| ROCE | 59.57% | ||
| ROIC | 37.3% | ||
| ROICexc | 39.73% | ||
| ROICexgc | 50.01% | ||
| OM | 31.09% | ||
| PM (TTM) | 24.41% | ||
| GM | 61.54% | ||
| FCFM | 19.18% |
ROA(3y)25.87%
ROA(5y)26.7%
ROE(3y)74.71%
ROE(5y)84.83%
ROIC(3y)35.08%
ROIC(5y)36.07%
ROICexc(3y)39.8%
ROICexc(5y)41.54%
ROICexgc(3y)51.52%
ROICexgc(5y)54.69%
ROCE(3y)52.73%
ROCE(5y)50.92%
ROICexcg growth 3Y-5.99%
ROICexcg growth 5Y4.29%
ROICexc growth 3Y-3.86%
ROICexc growth 5Y4.07%
OM growth 3Y0.02%
OM growth 5Y4.78%
PM growth 3Y-0.55%
PM growth 5Y5.09%
GM growth 3Y1.27%
GM growth 5Y1.47%
F-Score7
Asset Turnover1.21
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.71 | ||
| Debt/FCF | 1.43 | ||
| Debt/EBITDA | 0.74 | ||
| Cap/Depr | 95.5% | ||
| Cap/Sales | 3.26% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 65.03% | ||
| Profit Quality | 78.56% | ||
| Current Ratio | 1.11 | ||
| Quick Ratio | 0.79 | ||
| Altman-Z | 21.49 |
F-Score7
WACC9.06%
ROIC/WACC4.12
Cap/Depr(3y)119.66%
Cap/Depr(5y)117.12%
Cap/Sales(3y)3.91%
Cap/Sales(5y)3.89%
Profit Quality(3y)79.31%
Profit Quality(5y)83.23%
High Growth Momentum
Growth
EPS 1Y (TTM)12.45%
EPS 3Y9.32%
EPS 5Y18.18%
EPS Q2Q%20.2%
EPS Next Y14.26%
EPS Next 2Y13.24%
EPS Next 3Y13.08%
EPS Next 5Y11.68%
Revenue 1Y (TTM)6.68%
Revenue growth 3Y6.62%
Revenue growth 5Y10.12%
Sales Q2Q%10.55%
Revenue Next Year9.02%
Revenue Next 2Y8.62%
Revenue Next 3Y8.63%
Revenue Next 5Y8.69%
EBIT growth 1Y15.86%
EBIT growth 3Y6.64%
EBIT growth 5Y15.38%
EBIT Next Year29.28%
EBIT Next 3Y15.92%
EBIT Next 5Y14.07%
FCF growth 1Y30.65%
FCF growth 3Y7.86%
FCF growth 5Y21.29%
OCF growth 1Y21.32%
OCF growth 3Y7.13%
OCF growth 5Y15.13%